Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-12-039586
Filing Date
2012-07-16
Accepted
2012-07-16 14:33:15
Documents
16
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v317170_10k.htm 10-K 639834
2 EXHIBIT 10.2 v317170_ex10-2.htm EX-10.2 9693
3 EXHIBIT 10.3 v317170_ex10-3.htm EX-10.3 9737
4 EXHIBIT 21.1 v317170_ex21-1.htm EX-21.1 1546
5 EXHIBIT 31.1 v317170_ex31-1.htm EX-31.1 9435
6 EXHIBIT 31.2 v317170_ex31-2.htm EX-31.2 9390
7 EXHIBIT 32.1 v317170_ex32-1.htm EX-32.1 4429
8 EXHIBIT 32.2 v317170_ex32-2.htm EX-32.2 4556
15 GRAPHIC logo.jpg GRAPHIC 26772
16 GRAPHIC logo1.jpg GRAPHIC 26804
  Complete submission text file 0001144204-12-039586.txt   2210260

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT tglp-20120331.xml EX-101.INS 180095
10 XBRL TAXONOMY EXTENSION SCHEMA tglp-20120331.xsd EX-101.SCH 14077
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tglp-20120331_cal.xml EX-101.CAL 36168
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tglp-20120331_def.xml EX-101.DEF 92975
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE tglp-20120331_lab.xml EX-101.LAB 124927
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tglp-20120331_pre.xml EX-101.PRE 111632
Mailing Address 125 MAIDEN LANE, SUITE 309 NEW YORK NY 10038
Business Address 125 MAIDEN LANE, SUITE 309 NEW YORK NY 10038 212-797-9877
Tongli Pharmaceuticals (USA), Inc. (Filer) CIK: 0001052284 (see all company filings)

EIN.: 841090791 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52954 | Film No.: 12963575
SIC: 2834 Pharmaceutical Preparations